T ranscription factors of the rel family regulate transcriptional programs that underlie a functionally diverse spectrum of biologic responses that are of particular relevance to the generation of an immune response. The rel family consists of NF-B proteins, NFATc proteins, and the most recently identified member, NFAT5 (also designated TonEBP, NFATL1, OREBP). NF-B proteins (which include Rel-A, NF-B1, NF-B2, c-Rel, and Rel-B) are activated during both innate and adaptive immune responses and in response to certain cellular stresses (1) (2) (3) . NF-B-dependent transcriptional responses regulate cytokine expression, cell survival, and cell proliferation (2, 4, 5) . NFATc proteins (consisting of NFATc1 through NFATc4) represent a distinct group of rel proteins defined by a common regulatory domain that is the target of the calcium/calmodulin-dependent protein phosphatase calcineurin (6) . Calcium-dependent activation of NFATc proteins regulates transcriptional programs involved in lymphocyte development, activation, and differentiation (6) , as well as development of the heart, the vasculature, and potentially the nervous system (7, 8) . NFAT5, however, does not contain a calcineurin-dependent regulatory domain and precedes NFATc proteins in evolutionary development (9) . In marked contrast to NF-B and NFATc proteins, the biologic function of NFAT5 remains poorly understood.
The NFAT5 transcription factor was originally identified as tonicity enhancer binding protein (TonEBP) based on its ability to bind to tonicity response elements present in the upstream regulatory region of genes that are induced upon hypertonic stress (10) . Known NFAT5 target genes encode proteins that function to increase the intracellular concentration of compatible (i.e., organic) osmolytes and thus compensate for increased extracellular tonicity. These include aldose reductase (AR 3 ; Ref. 11), the sodium/myoinositol transporter (12) , and the betaine/␥-aminobutyric acid transporter (13) . Although NFAT5 exhibits variable nucleocytoplasmic localization in different cell lines, hyperosmotic stress induces clear nuclear translocation (10, 14) . Additionally, NFAT5-dependent reporter gene expression is markedly induced by hypertonicity (10, 15) . These observations have led to the hypothesis that NFAT5 functions physiologically within the kidney to counteract the potentially deleterious consequences of the hypertonic environment of the renal medulla (16) . In support of this hypothesis, NFAT5 protein was observed to be localized to the nucleus of renal medullary epithelial cells of rats in which the osmolarity of the renal medulla was elevated by dehydration. Moreover, this nuclear localization correlated with increased expression of the sodium/myoinositol transporter gene (17) . NFAT5 thus appears to play an important role in allowing cells to compensate for hyperosmotic stress under tissue culture conditions or within the hyperosmotic environment of the renal medulla. However, direct functional data to support this hypothesis remains lacking.
The possibility that NFAT5 subserves broader or perhaps alternative functions in vivo, however, is suggested by several observations. First, NFAT5 RNA expression is not limited to the kidney, Departments of Pathology and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093 but is in fact ubiquitous (10, 15, 18) . Analysis of protein expression further indicates that NFAT5 is expressed in essentially all tissues of the developing embryo, with particularly high levels of expression in the brain and heart (19) . In adult tissues detectable NFAT5 protein is limited to the thymus and mitogen-activated primary T lymphocytes (15) . Despite the apparent lack of expression of NFAT5 protein in most tissues, NFAT5 is readily detectable by Western blot analysis in most transformed cell lines (Refs. 10, 15, and 18 and our unpublished observations). NFAT5 protein expression thus appears to correlate with cell growth. Second, the extremes of hypertonicity present within the renal medulla do not appear to exist in any other tissue under physiologic conditions. Third, NFAT5-dependent transcription can be induced not only by hypertonicity but also by TCR-dependent signaling events (15) . Fourth, in addition to osmoregulatory genes, NFAT5 has been demonstrated to play a role in the expression of cytokine genes such as TNF-␣ and lymphotoxin ␤ in response to a combination of hypertonic and mitogenic signals (20) . And fifth, a novel Drosophila rel domain protein designated MESR1, which is more similar to NFAT5 than to any other NFAT or rel family member, was identified in an overexpression screen and shown to be capable of suppressing RAS-dependent signaling (21) . This gene was also identified in an overexpression screen for axon guidance/synaptogenesis phenotypes (22) . Together these observations suggest that the function of NFAT5 may not be limited to regulating transcription in response to hypertonic stress, as occurs in the renal medulla. Rather, NFAT5 may function more broadly and under isotonic conditions to regulate transcriptional responses that permit optimal cell growth and function.
In the present study the biologic function of NFAT5 in vivo was evaluated through the use of transgenic mice that express a dominant inhibitory form of NFAT5. Given previous studies demonstrating expression of the NFAT5 protein in thymus and activated T cells (15) , transgene expression was directed to thymus and mature peripheral T lymphocytes. Mice that express the transgene exhibited impaired thymic development and reduced numbers of mature T cells in spleen and lymph nodes, consistent with the constitutive nuclear localization of NFAT5 observed in thymocytes as well as both quiescent and activated T cells. Although transgenic T cells exhibited normal ex vivo proliferative responses and cytokine production under standard cell culture conditions, medium depletion and amino acid limitation resulted in impaired cell growth and reduced viability as compared with control mice. These results suggest that NFAT5 is not only important for optimal cell growth in vivo, but within the context of an isosmotic environment NFAT5 appears to play a role in optimally coordinating transcriptional programs in response to osmotic stresses to which cells are normally exposed in vivo during cell growth.
Materials and Methods

Generation of dominant-negative (DN) NFAT5 transgenic mice
A DNA fragment encoding the murine NFAT5 DNA binding domain (DBD; aa 267-543) was amplified by PCR from a murine NFAT5 cDNA clone (kindly provided by C. Antos and E. Olson (University of Texas Southwestern Medical Center, Dallas, TX); GenBank accession no. AF162853), transferred to an intermediate subcloning vector (pJT501t) to introduce a 3Ј influenza hemagglutinin (HA) epitope tag, and subsequently inserted into the EcoRI site of the CD2 transgene vector (23) , resulting in the transgene vector CD2 mDBD. The region spanning the murine NFAT5 DBD insert was verified by DNA sequencing (DNA Sequencing Shared Resource, University of California-San Diego Cancer Center). The transgene DNA fragment was separated from vector DNA by centrifugation through a 10 -40% sucrose gradient. Fractions containing the ϳ12-kb transgene fragment were pooled and exhaustively dialyzed against injection buffer (7.5 mM Tris (pH 7.4), 0.15 mM EDTA). Pronuclear injections of transgene DNA were performed by the University of California-San Diego Cancer Center Transgenic Mouse and Gene Targeting Core using CB6F1 hybrid embryos. Transgene-positive founders were identified by PCR from tail DNA using transgene-specific primers (5Ј-GCATAAG AGTCAAAGAAGTCCC and 5Ј-CTCCTTTCACTGAACAGCTATGC). Three founder lines (CD2DBD2, CD2DBD10, CD2DBD17) were generated and transgene expression was verified by Western blotting using the HA epitope-specific mAb HA.11 (1:4000; CRP, Denver, PA). The highest expressing transgenic lines (CD2DBD2 and CD2DBD10) were used in the present studies and gave similar results. All experiments were performed using transgenic mice backcrossed onto the C57BL/6 background at least five generations, with control mice consisting of transgene-negative littermates. Animals were maintained in accordance with University of California-San Diego animal care guidelines.
Cell preparation and culture
Splenocyte single cell suspensions were purified by density gradient centrifugation (Lympholyte M; Cedarlane Laboratories, Hornby, Ontario, Canada). CD4 ϩ and CD8 ϩ T lymphocytes were isolated to Ͼ95% purity by positive MACS using Ab-conjugated MicroBeads (Miltenyi Biotec, Auburn, CA) as per the manufacturer's instructions. Con A blasts were generated from splenocyte single cell suspensions. Cells were plated in complete medium as previously described (15) with 2.5 g/ml Con A (Calbiochem, La Jolla, CA) and 40 U/ml IL-2 (Roche, Basel, Switzerland) at 10 6 cells per milliliter for 48 h. Cells were washed, resuspended, and cultured as indicated. Isolated T cells were activated in tissue culture dishes precoated with anti-CD3 Ab (145-2C11; BD PharMingen, San Diego, CA) or as previously described (15) and supplemented with 2.5 g/ml anti-CD28 (37.51; BD PharMingen) and 40 U/ml IL-2. Jurkat E6 cell lines were cultured as described previously (15) . SV40 transformed murine ear fibroblasts (kindly provided by B. A. Hamilton, University of California at San Diego, La Jolla, CA) were cultured in DMEM containing high glucose supplemented with 10% heat-inactivated FBS, 100 U penicillin, and 100 g/ml streptomycin. Hyperosmotic conditions were maintained by incubation in complete medium containing 0.22-m filter-sterilized 100 mM sucrose (Fisher, Pittsburgh, PA), 50 -200 mM D(ϩ)raffinose (SigmaAldrich, St. Louis, MO), or 100 mM sodium chloride (Sigma-Aldrich) as indicated. Lymphocyte apoptosis was induced by incubation in complete medium containing 1 M dexamethasone (Calbiochem) or 250 ng/ml antifas Ab (Jo2; BD PharMingen) with 1 mg/ml protein G (Sigma-Aldrich) as indicated. Amino acid deprivation culture conditions were maintained by washing cells twice with Earl's balanced salt solution (EBSS) with Ca 2ϩ and Mg 2ϩ supplemented with 10% heat-inactivated, dialyzed FBS. Cell culture was then continued in the same EBSS with or without the addition of minimum essential and nonessential amino acids as indicated. For additional stimulation, cells were incubated with complete medium containing 1 M ionomycin (Calbiochem) and/or 10 ng/ml PMA (Calbiochem) unless otherwise indicated. Osmolarity of the culture medium was measured using a Wescor 5500 vapor pressure osmometer (Wescor, Logan, UT). Jurkat cell transfections and reporter gene analyses were performed as previously described (15) .
Generation of stable Jurkat cell lines
A full-length human NFAT5 cDNA clone containing two tandem C-terminal HA epitope tags (pSH320) was digested with BamHI. The resulting 4828-bp fragment was ligated into pBJ5-neo (a mammalian expression vector containing the neomycin resistance marker) to generate p5FL-neo. pJT501 was digested with NotI and EcoRI. The resulting 894-bp fragment was ligated into pBJ-neo to generate p5DBD-neo. Jurkat E6 cells (American Type Culture Collection, Manassas, VA) were electroporated as previously described (15) with 20 g of linearized (AtaI) pBJ-neo (control), p5FL-neo, or p5DBD-neo plasmid DNA. Cells were plated into 96-well plates by limiting dilution and cultured in complete medium containing 800 g/ml G418. Three independent clones of the pBJ-neo control were maintained. Three independent clones for each of the NFAT5 constructs were identified based on Western analysis of expression of the HA epitopetagged expression cassette. Cells were removed from G418 selection at least 48 h before experiments. ϩ T cells were activated in triplicate in 2-ml cultures in a 12-well culture dish, or 0.2 ϫ 10 6 /ml Jurkat E6 cells were cultured in triplicate in 1-ml cultures in a 24-well culture dish. At the indicated times cells were counted and viability was assessed by flow cytometric determination of propidium iodide (PI; Calbiochem) exclusion. The number of viable cells was calculated by multiplying total cell number by the percentage of cells that were PI negative. Similar results were obtained by trypan blue (Life Technologies, Gaithersburg, MD) exclusion. In vivo bromodeoxyuridine (BrdU) incorporation was performed with 4-to 6-wk-old mice. Mice were injected i.p. with 1 M BrdU (BD PharMingen) in PBS. One hour later thymus and spleen were harvested and cells were fixed in ice-cold 70% ethanol for 30 min at Ϫ20°C. Cells were then processed for staining with a FITC-conjugated anti-BrdU Ab (BD PharMingen) according to the manufacturer's instructions. Finally, cells were resuspended in PBS containing 10 g/ml PI and cell cycle distribution (DNA vs BrdU) was analyzed by flow cytometry.
Cell growth assays
Immunofluorescence
Fibroblasts were seeded on coverslips in 12-well tissue culture dishes at 50% confluence and allowed to grow to at least 70% confluence. Thymocyte samples were prepared by rapid isolation and dispersal of single cell suspensions through a 70-m filter into ice-cold PBS. Thymic subsets (CD4 and CD8 double negative, double positive, and single positive) were isolated by fluorescence cell sorting using CD4-FITC and CD8-PE marker Abs (BD PharMingen). CD4
ϩ T cells were isolated and activated as described. Thymocytes and CD4 ϩ T cells were cytospun (5 min at 600 rpm; Cytospin-3; Thermo Shandon, Pittsburgh, PA) onto poly-L-lysine-coated slides (Sigma-Aldrich). Attached cells were fixed in 4% formaldehyde for 10 min and washed three times in PBS. Fixed cells were blocked and permeabilized by incubation in PBS containing 5% donkey serum and 0.2% Triton X-100 for 30 min. Incubation with 1:1000 rabbit polyclonal anti-NFAT5 Ab (15) was performed for 1 h in the same blocking/permeabilization solution diluted 1/1 in PBS. Cells were then washed five times in PBS and incubated for 1 h with a Cy3-conjugated anti-rabbit secondary Ab (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted 1/500 in PBS with 2% donkey serum. Cells were then washed three times and stained with DAPI (Sigma-Aldrich) for 5 min. All incubations were performed at room temperature. Deconvolution images were obtained through the University of California-San Diego Cancer Center Digital Imaging Shared Resource. Images were captured with a DeltaVision deconvolution microscopy system (Applied Precision, Issaquah, WA). Individual images were derived from 10 -20 optical sections obtained at 0.2-m increments. The data sets were deconvolved and analyzed using SoftWorx software (Applied Precision) on a Silicon Graphics Octane workstation. For accurate quantitation of NFAT5 expression in lymphocytes, exposure times and Cy3 signal scaling were kept constant between images as indicated, and fluorescence intensity values were obtained from nondeconvolved images using the Data Inspector program in SoftWorx. NFAT5 expression was quantitated by determining Cy3 fluorescence intensity per cell as a mean of at least 30 cells in a representative ϫ20 field. Similar results were obtained by determining mean Cy3 fluorescence intensity within 10 -20 uniformly staining regions within a single cell (ϫ100).
RNA analysis
RNA was isolated from Con A blasts using TRIzol (Invitrogen, San Diego, CA), and 15 g of total RNA per sample was size-fractionated on a 1% formaldehyde-agarose gel. Radiolabeled cDNA fragments used as probes consisted of the following: a 1267-bp EcoRI-XhoI fragment from a murine AR cDNA expressed sequence tag (EST) clone (GenBank accession no. AA791571; American Type Culture Collection), an ϳ850-bp EcoRI-NotI fragment from a murine ATA2 cDNA EST clone (GenBank accession no. AA764095; Research Genetics, Huntsville, AL), a 1110-bp EcoRI-NotI fragment from a murine TNF-␣ cDNA EST clone (GenBank accession no. AA920586; Research Genetics), and a murine GAPDH fragment (Ambion, Austin, TX). Hybridizations and high stringency washes were performed using standard procedures. RNA levels were quantitated by phosphorescence using a Storm Phosphoimaging system and ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Fold induction values were calculated after normalization to the GAPDH signal.
Flow cytometry
mAbs used for flow cytometric analyses were obtained from BD PharMingen and include anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-B220
, and anti-BrdU (3D4). Flow cytometry was performed on a FACScan flow cytometer using CellQuest software (BD Biosciences, Palo Alto, CA).
Statistical analyses
All data represent the mean of independent experiments. Error values represent the SEM calculated from a minimum of three experiments. Student's t test was performed to determine significance.
Results
Constitutive nuclear localization of NFAT5 in thymocytes and activated T cells
NFAT5 protein localizes to both the cytoplasm and nucleus in tissue culture cell lines. Exposure to hypertonic culture conditions induces marked cytoplasmic clearing and concentration of NFAT5 in the nucleus concomitant with an overall increase in NFAT5 staining (10, 14, 18 -20, 24) . In previous studies NFAT5 RNA was shown to be ubiquitously expressed, while NFAT5 protein was readily detectable only in thymus or in activated T lymphocytes (15) . To investigate the potential role of NFAT5 in T cell development and activation, the nucleocytoplasmic distribution of NFAT5 protein in primary thymocytes and CD4
ϩ T cells was determined by deconvolution immunofluorescence microscopy using an antiserum raised to the DBD of NFAT5 (15) . As a control for NFAT5 staining, primary murine dermal fibroblasts were cultured under isotonic or hypertonic conditions for 2 h. As expected (24) , primary skin fibroblasts exhibited constitutive nuclear NFAT5 staining under isotonic culture conditions as well as diffuse cytoplasmic staining. Exposure to hypertonic culture conditions resulted in the complete elimination of NFAT5 from the cytoplasm (Fig. 1, A vs B) , thus validating the specificity of the antisera for immunohistochemical localization of NFAT5. Primary murine thymocytes were isolated and flow sorted into CD4 and CD8 double-negative, double-positive, and single-positive subsets. Cells of each thymic subset exhibited equally strong, multifocal nuclear staining for NFAT5, with little or no detectable cytoplasmic staining, indicating that NFAT5 is not differentially expressed or regulated during thymic development ( Fig. 1 , E-H). Interestingly, there was a clear inverse relationship between NFAT5 staining and the DAPI nuclear counterstain. Given that DAPI most strongly stains areas of condensed, heterochromatic DNA, this result suggests that NFAT5 is potentially localized to areas of more accessible, transcriptionally active euchromatic DNA. Staining of quiescent CD4 ϩ T cells demonstrated low but detectable NFAT5 staining in the nucleus in a pattern similar to that seen in thymocytes, as well as detectable cytoplasmic staining (Fig. 1C) . Although prior Western analysis of NFAT5 protein expression in quiescent T cells demonstrated no detectable immunoreactivity (15) , immunofluorescence microscopy represents a more sensitive method of detection. CD4 ϩ T cell blasts activated with anti-CD3 plus anti-CD28 exhibited significantly increased NFAT5 staining that was localized to the nucleus with no detectable cytoplasmic staining (Fig. 1D) . Quantitation of NFAT5 expression observed by immunofluorescence microscopy demonstrates that NFAT5 is induced in activated T cells to a level similar to that present in thymocytes ( Fig. 1, inset) , consistent with results from Western analysis of thymus and peripheral T cells (15) . The nuclear localization of NFAT5 in thymocytes as well as quiescent and activated T cells and the marked induction of NFAT5 protein expression upon T cell activation suggest that NFAT5 is potentially active during both thymic development and T cell activation.
Inhibition of NFAT5 function in DN NFAT5 transgenic mice
In an effort to further define the physiologic function of NFAT5 in vivo, expression of an inhibitory (i.e., DN) form of NFAT5 was directed to thymus and mature peripheral T cells using the human CD2 transgene expression vector (23) . The DN NFAT5 transgene consists of the isolated DBD ( Fig. 2A) , which has been shown previously to significantly inhibit endogenous NFAT5 transcriptional activity in cell-based transient transfection assays (10, 15) , most likely by interfering with NFAT5 dimerization (20, 25) . The specificity of the DN NFAT5 was further validated in additional reporter gene assays which demonstrated that, while expression of DN NFAT5 inhibited inducible transcription mediated by NFAT5 binding sites, there was no inhibition of transcription mediated by NFATc, NF-B, or AP1 DNA binding sites (Fig. 2B ). Western FIGURE 2. Generation of DN NFAT5 transgenic mice. A, Schematic representation of the DN NFAT5 transgene in comparison of wild-type NFAT5 (isoform C). B, DN NFAT5 was expressed in Jurkat T cells by transient transfection together with hTonE, NFATc, NF-B, and AP1 responsive reporter genes. Cells were activated and reporter gene activity was assayed as described previously (15) . Inhibition of reporter gene induction by DN NFAT5 is expressed as a percentage of reporter activity obtained in cells transfected in parallel with a vector control plasmid (n ϭ 3 independent transfections). C, DN NFAT5 expression in isolated thymocytes and splenocytes from three independent transgenic lines. The HA epitope of the transgene-encoded protein was measured by Western blotting. D, Con A blasts (1 ϫ 10 6 /ml) were cultured for 16 h in isosmotic (Ϫ) or hyperosmotic conditions (ϩ; 200 mM raffinose). Total cellular RNA was prepared and Northern analysis of the expression of the indicated genes was performed. E, Fold induction of AR mRNA in response to a hyperosmotic stimulus, normalized to GAPDH, in nontransgenic vs transgenic T cells (quantitated from Northern analyses of independent RNA preparations, n ϭ 3). analysis of several independent DN NFAT5 transgenic lines demonstrated strong expression of the DN NFAT5 transgene in both thymus and spleen (Fig. 2C ). To verify that transgenic expression of the NFAT5 DBD results in the functional inhibition of the endogenous NFAT5 protein, inducible expression of the AR gene upon hypertonic stress was analyzed in nontransgenic vs transgenic mice. AR is an NFAT5 target gene that is induced upon hyperosmotic stimulation (26 -28) . Previous studies demonstrated that expression of the NFAT5 DBD is capable of inhibiting the hyperosmotic induction of the endogenous AR gene in cell lines (28) . As expected, hyperosmotic induction of AR mRNA in primary T lymphocytes was reduced by ϳ40 Ϯ 5.2% (n ϭ 3) in cells expressing the DN NFAT5 transgene as compared with nontransgenic controls after normalization to the level of GAPDH mRNA expression (Fig. 2, D and E) . This level of inhibition mediated by overexpression of the NFAT5 DBD is similar to that observed in transfected cell lines (28) .
To further validate the specificity and function of the DN NFAT5 transgene, cell viability under ex vivo hyperosmotic conditions was measured in an effort to determine whether NFAT5 is in fact osmoprotective for cells placed in a hypertonic environment. Splenocyte cultures were activated with Con A for 48 h. The cells were subsequently cultured in complete medium alone or with the addition of raffinose for 16 h. After the 16-h culture period, T cells expressing the DN NFAT5 transgene exhibited reduced viability under hyperosmotic culture conditions as compared with cells derived from nontransgenic controls (Fig. 3A) , consistent with the role of NFAT5 in regulating transcription of osmoprotective genes. The specificity of the observed increased sensitivity of DN NFAT5 transgenic cells to hypertonic stressdependent cell death was established by investigating the sensitivity of these cells to either growth factor withdrawal or fas-dependent cell death. While DN NFAT5 transgenic cells exhibited increased sensitivity to hypertonic stress, the decrease in viability associated with either growth factor withdrawal or the induction of apoptosis by cross-linking fas was identical in both transgenic and nontransgenic cells (Fig. 3B) . The sensitivity of thymocytes to hypertonic stress was also determined. Thymocytes were placed into culture containing varying concentrations of raffinose, and cell viability was assessed 12 h later. Under these conditions thymocytes from DN NFAT5 transgenic mice also exhibited increased sensitivity to hypertonic stress (Fig. 3C) . However, induction of cell death by either incubation with dexamethasone or anti-fas Abs showed no difference comparing transgenic and nontransgenic cells (Fig. 3D) . These results indicate that the DN NFAT5 transgene specifically inhibits endogenous NFAT5 function and further demonstrate the osmoprotective function of NFAT5 in primary cells under ex vivo hypertonic tissue culture conditions. Although NFAT5 has been demonstrated to regulate the expression of genes such as AR that mediate the induction of compatible osmolytes in response to hyperosmotic stress, these results represent the first functional data that demonstrate a role for NFAT5 in protecting cells from cell death induced by hyperosmotic stress.
Impaired T cell development in DN NFAT5 transgenic mice
To determine whether inhibition of NFAT5 function in vivo influences thymic development, the cellularity of the thymus and spleen of nontransgenic and transgenic mice was compared. Thymuses from transgenic mice exhibited a 30% reduction in cellularity as compared with nontransgenic mice, while transgenic spleen exhibited a 15% decrease in overall cellularity (Fig. 4A) . To determine whether the reduction in splenic cellularity reflected a reduction in the number of mature peripheral T cells, the percentages of CD4 ϩ and CD8 ϩ T cells present in both spleen and peripheral lymph node were determined by flow cytometry. Spleen from DN NFAT5 transgenic mice exhibited a 50% reduction in the percentage of CD8 ϩ T cells and a 25% reduction in the percentage of CD4 ϩ T cells (Fig. 4B ). Given the observed frequencies of CD4 ϩ and CD8 ϩ cells in the spleen, the overall reduction in splenic cellularity observed in the transgenic mice is accounted for by a reduction in the absolute number of CD4 ϩ and CD8 ϩ T cells. A reduction in the percentage of CD8 ϩ T cells was also observed in cells obtained from peripheral lymph nodes (Fig. 4C) . To determine whether the reduction in T cell population functionally affected the ability of DN NFAT5 transgenic mice to elicit an Ag-specific immune response in vivo, nontransgenic and transgenic mice were immunized intradermally with plasmid DNA encoding ␤-galactosidase in a CMV-based expression vector (29, 30) . As expected, DN NFAT5 transgenic mice developed impaired Ag-specific Ab and cytotoxic T cell responses that correlated with a reduction in the frequency of Ag-specific precursor cells as determined by IFN-␥ ELISPOT and with the reduced frequency of CD4 ϩ and CD8 ϩ T cells in the transgenic mice (data not shown). These results indicate that inhibition of NFAT5 function in vivo results in impaired thymic development associated with peripheral T cell lymphopenia, which, not surprisingly, gives rise to impaired immune responses. The reduced number of peripheral T cells is likely secondary to the observed impairment in thymic development. However, peripheral T cell expansion via homeostatic mechanisms regulating Ag-independent T cell proliferation may also occur independent of thymic influence. Therefore, these results do not exclude the possibility that NFAT5 may play a role in regulating peripheral T cell homeostasis independent of a role in regulating thymic development.
To further characterize the reduction in thymic cellularity associated with the DN NFAT5 transgene, thymocyte subsets were enumerated to monitor defined thymic developmental transitions. Flow cytometric analysis showed no differences in the percentages of thymic subsets defined by the CD4 and CD8 markers (Fig. 4D) . These results indicate that the observed reduction in overall size (i.e., cellularity) of thymus from DN NFAT5 transgenic mice is equally distributed among all thymic subsets and therefore is not the result of inhibition of a specific thymic developmental transition. To determine whether the observed reduction in thymic cellularity was due to a reduction in the rate of cell proliferation in the thymus, the percentage of thymocytes in S phase of the cell cycle was determined by measuring BrdU incorporation in vivo. One hour after injection of BrdU, thymocytes were isolated and the frequency of BrdU-positive cells was determined by flow cytometry. Essentially identical percentages of BrdU-positive cells were observed in nontransgenic (8.0 Ϯ 0.2%, n ϭ 6) and transgenic (8.2 Ϯ 0.5%, n ϭ 6) thymuses. This result indicates that there was no significant difference in the proliferative rate of thymocytes that might account for the reduction in overall thymic cellularity. In contrast, parallel analysis of splenocytes by in vivo BrdU incorporation demonstrated a significant ϳ70% reduction in BrdU-positive cells present in the spleen of transgenic animals (2.1 Ϯ 0.5%, n ϭ 3) as compared with nontransgenic controls (6.0 Ϯ 0.4%, n ϭ 3). This reduction in the percentage of transgenic splenocytes in S phase likely reflects the observed reduction in the number of T cells in the spleen.
Normal function of DN NFAT5 transgenic T cells under non-stress culture conditions
As a broad assay of T cell function, the proliferative responses of purified splenic CD8 ϩ T cells from transgenic and nontransgenic littermate control mice were quantitated by tritiated thymidine incorporation, which reflects the number of cells in S phase of the cell cycle. Cells were stimulated with plate-bound anti-CD3 plus anti-CD28 in the presence of excess exogenous IL-2 and subjected to 12-h pulses of [ 3 H]thymidine at varying times after stimulation. Culture medium was replenished 2 days after stimulation. Both transgenic and nontransgenic T cells exhibited similar proliferative responses (Fig. 5A) . Moreover, both control and transgenic T cells ϩ and CD8 ϩ cell populations were quantitated by flow cytometry.
FIGURE 5.
T lymphocytes from DN NFAT5 transgenic mice function normally under optimal growth conditions. A, Isolated CD8 ϩ splenocytes were activated with anti-CD3, anti-CD28, and IL-2, and [ 3 H]thymidine incorporation was measured daily. Fresh medium containing IL-2 was provided 2 days after activation to maintain optimal growth conditions. B, Cytokine production by Con A blasts was measured by intracellular cytokine staining, which was performed 6 h after stimulating the cells with ionomycin (1 M) and PMA (10 ng/ml) exhibited essentially identical cell growth over the course of a 6-day culture period based on direct quantitation of cell number (data not shown). As an additional measure of T cell activation, intracellular cytokine analyses were performed. Splenocyte preparations were stimulated with Con A and analyzed for intracellular cytokine production 48 h later. The number of IL-2-and IFN-␥-positive cells, as a percentage of either CD4 ϩ or CD8 ϩ cells, was the same when comparing transgene-negative vs transgene-positive T cells (Fig. 5B) . The stimulation conditions used in these experiments preferentially allowed differentiation and expansion of IFN-␥-producing Th1 cells rather than IL-4-producing Th2 cells. However, under conditions that induce differentiation of Th2 cells, IL-4 production by transgene-negative and transgene-positive cells also showed no significant difference (data not shown). In addition, there were no differences in TCR expression, as measured by CD3⑀ expression, or in the activation-dependent inducible expression of CD25 and CD69, which represent cell surface markers of T cell activation (data not shown). Together these results indicate that under standard ex vivo cell culture conditions, inhibition of NFAT5 function has no significant effect on T cell growth or effector function (i.e., cytokine production).
Impaired growth of DN NFAT5 transgenic T cells under conditions of medium depletion
As described above, DN NFAT5 transgenic T cells and thymocytes exhibit reduced viability upon exposure to hypertonic culture conditions as compared with nontransgenic cells. However, the control nontransgenic cells also exhibited significant cell death (Fig. 3, A and C) , reflecting the highly toxic and nonphysiologic nature of this culture condition. The rapid, essentially instantaneous transition from isotonic to hypertonic culture conditions represents a stress that is unlikely to occur in vivo. Moreover, the rapid transition to a hypertonic environment does not allow sufficient time to induce compensatory mechanisms, thus resulting in significant cell death. To further investigate the growth response of DN NFAT5 transgenic T cells under hypertonic stress conditions, cells were cultured under conditions of medium depletion in which tissue culture medium is not replenished over time. Continuous culture without medium exchange results in gradually increasing osmolarity of the medium over time in culture (see Fig. 6E ). As previously demonstrated (Fig. 5A) , at early time points after activation of isolated CD8 ϩ T cells both control and transgenic cells proliferated equally. However, at later time points in extended culture under conditions of medium depletion the DN NFAT5 transgenic T cells showed a markedly reduced rate of incorporation of [ 3 H]thymidine (Fig. 6A) . Moreover, direct quantitation of cell expansion after stimulation demonstrated a reduction in cell numbers at later time points (Fig. 6B) , consistent with results from the proliferation assay. Thus, DN NFAT5 transgenic T cells exhibited impaired cell growth under conditions of medium depletion that was not observed in control mice. Interestingly, in parallel experiments transgenic cells exhibited no increased sensitivity to a reduction in pH or even serum deprivation (data not shown), suggesting that the sensitivity to medium depletion may be due specifically to an increase in the osmolarity of the medium.
To further demonstrate a potential role for NFAT5 in regulating optimal cell growth in response to suboptimal growth conditions of medium depletion, stable Jurkat cell lines expressing either the DN or full-length NFAT5 were generated using expression vectors that incorporate a neomycin resistance marker. Cell lines expressing the selectable marker alone were generated in parallel as controls. Three independent clones of each line were analyzed. Under normal culture conditions the stable lines exhibited no differences in growth rate. However, under conditions of medium depletion clones that overexpress NFAT5 exhibited higher density cell growth associated with reduced cell death as compared with control cells, while clones expressing DN NFAT5 exhibited an impaired capacity for high-density cell growth that was associated with increased cell death (Fig. 6, C and D) . Measurement of the osmolarity of the medium over the culture period demonstrated a 23% increase in osmolarity (Fig. 6E) . These results are consistent with the observed impairment in cell growth of primary T cells expressing the DN NFAT5 transgene under conditions of medium depletion, and further demonstrate the growth advantage conferred by overexpression of NFAT5. Similar to results with primary T cells, differences in growth/survival of the stably transfected cell lines were not apparent at early time points in the culture but were detectable only later (i.e., day 3 or later). Together these results clearly demonstrate that NFAT5 functions to permit optimal cell growth under suboptimal growth conditions associated with medium depletion.
Impaired growth of DN NFAT5 transgenic T cells in response to amino acid deprivation
Amino acid deprivation under isotonic conditions has been demonstrated to induce a decrease in cell volume and an increase in intracellular potassium, thus representing an osmotic stress condition (24, 31, 32) . Of particular interest, amino acid deprivation also induced NFAT5 nuclear localization (24) . To investigate whether the impaired growth of DN NFAT5 transgenic T cells observed under conditions of medium depletion could also be manifest by amino acid deprivation, T cells from transgenic and littermate control mice were subject to culture in medium containing varying concentrations of amino acids. As expected, culture in medium containing no amino acids resulted in essentially no proliferation as measured by [ 3 H]thymidine uptake. However, at suboptimal concentrations of amino acids, DN NFAT5 transgenic T cells exhibited a greater inhibition of proliferation compared with T cells from littermate control mice (Fig. 7A) .
Given that the DN NFAT5 transgenic mice exhibited a defect in thymic development in vivo, the sensitivity of thymocytes to amino acid deprivation ex vivo was analyzed. Thymocytes were isolated from transgenic and nontransgenic littermate control mice and placed into culture with and without added amino acids. Cell viability was analyzed after a culture period of 36 h. Thymocytes from transgenic animals exhibited a slight although reproducibly greater decrease in viability upon culture in medium lacking amino acids than did thymocytes from transgene-negative littermate control mice (Fig. 7B ). These results demonstrate that inhibition of endogenous NFAT5 activity resulting from expression of the DN NFAT5 transgene results in an increased sensitivity of thymocytes to conditions of limiting amino acids. Thus, osmotic stress induced not only by exposure to a hypertonic environment (e.g., addition of raffinose), but also by amino acid limitation under isotonic conditions (24, 31, 32) , results in impaired cell viability in cells from DN NFAT5 transgenic mice as compared with nontransgenic controls.
Analysis of potential NFAT5 target genes: ATA2 and TNF-␣
To further investigate the impaired viability of cells from DN NFAT5 transgenic mice upon exposure to either hypertonic conditions or amino acid deprivation, the expression of AR mRNA was compared with that of the system A transporter ATA2 (Fig. 8,   A and B) . The system A amino acid transport system is a sodiumdependent transport system for neutral amino acids that exhibits osmosensitivity (32) . The induction of the ATA2 gene by hypertonicity (33, 34) and the nuclear localization of NFAT5 in response to amino acid deprivation (24) suggests that NFAT5 may play a role in regulating transcription of this gene. Exposure of nontransgenic T cell blasts to either hypertonicity or amino acid deprivation resulted in a similar induction of AR mRNA. The magnitude of induction is less than that observed previously (Fig. 2, D and E) because the duration of the induction was shortened (6 vs 16 h) to optimize for the induction of ATA2. In DN NFAT5 transgenic T cells the induction of AR mRNA by either hypertonicity or amino acid deprivation was reduced relative to nontransgenic cells, consistent with a role for NFAT5 in the transcriptional regulation of the AR gene in response to hyperosmotic stress. ATA2 mRNA was also induced by both hypertonicity and amino acid deprivation, although the magnitude of induction by amino acid deprivation was significantly greater. However, while the induction of the ATA2 gene by hypertonicity was inhibited in the DN NFAT5 transgenic cells, induction by amino acid deprivation was not inhibited. These results indicate that, in contrast to the AR gene in which NFAT5 plays a role in the induction in response to either amino acid deprivation or hypertonicity, the ATA2 gene exhibits NFAT5 dependence only in the context of a hypertonic stimulus, suggesting that amino acid deprivation activates transcriptional programs independent of NFAT5 that are capable of regulating the ATA2 gene.
Previous studies have also demonstrated that NFAT5 plays a role in the induction of the TNF-␣ gene in response to a combined stimulus of hypertonicity and PMA. Specifically, stimulation of primary T cell blasts with PMA plus 100 mM NaCl resulted in the induction of TNF-␣ protein expression (20) . To determine whether TNF-␣ gene expression was altered in DN NFAT5 transgenic mice, T cell blasts were rested for 16 h, then stimulated with ionomycin plus PMA or 100 mM NaCl plus PMA for 8 h and RNA was isolated for Northern analysis. The overall yield of RNA from cells stimulated with 100 mM NaCl plus PMA was reduced ϳ55% as compared with all other samples, reflecting the toxicity of the hypertonic stimulus. Analysis of TNF-␣ gene expression, normalized to the level of GAPDH mRNA expressed, demonstrated that ionomycin plus PMA induced TNF-␣ mRNA expression equally in both transgenic and nontransgenic cells. Moreover, stimulation with 100 mM NaCl plus PMA resulted in a significant inhibition of TNF-␣ mRNA in both transgenic and nontransgenic cells (Fig. 8,  C and D) . These results indicate that the TNF-␣ gene is not induced by hypertonicity. Moreover, NFAT5 does not appear to play a role in the regulation of TNF-␣ mRNA expression.
Discussion
The NFAT5/TonEBP transcription factor is activated by hyperosmotic stress and regulates the transcription of target genes that increase the intracellular concentration of compatible organic osmolytes. The accumulation of osmolytes functions to compensate for the cell volume reduction induced by the hyperosmotic environment by allowing for the osmotic influx of water into the cell (35) . Induction of NFAT5-dependent transcription in response to hypertonic stress is therefore very likely critical to the survival of cells exposed to a hyperosmotic environment, such as cells within the renal medulla (16, 17) . However, the ubiquitous expression of NFAT5 mRNA in tissues not exposed to hypertonic conditions (10, 15, 18) and the expression of NFAT5 protein in highly proliferative tissues or cells (e.g., developing embryo, thymus, activated T cells, most cell lines (15, 19) ) suggest that the function of NFAT5 may not be limited to regulating transcription in response to overt hyperosmotic stress. Consistent with this, previous studies have demonstrated that both NFAT5 protein expression and NFAT5-dependent transcription can be induced during T cell activation upon cross-linking of the TCR and by stimulation with the combination of a calcium ionophore and phorbol ester (15, 20) . Therefore, the present study sought to further define the function of NFAT5 in vivo under physiologically isosmotic conditions, focusing on thymic development and T cell function.
Biologic function of NFAT5 in vivo
Inhibition of NFAT5 function in thymocytes and mature peripheral T cells in vivo through the development of transgenic mice expressing an inhibitory or DN NFAT5 transgene demonstrated a significant reduction both in thymic cellularity and in the number of mature peripheral T cells, particularly CD8 ϩ T cells. These results imply a role for NFAT5 in T cell development and clearly demonstrate that NFAT5 functions in vivo under normal physiologic conditions not associated with overt hypertonic stress. These results are consistent with the observed constitutive nuclear localization of NFAT5 in thymocytes and quiescent or activated T cells (Fig. 1) , as well as the previously demonstrated induction of NFAT5 protein and transcriptional activity upon T cell activation under isotonic conditions (15) . Although the present study restricted the inhibition of NFAT5 function in vivo to thymus and mature T cells, inhibition of NFAT5 in other cell types may also result in similarly impaired cell growth or development given the ubiquitous nature of NFAT5 expression (15, 19) .
Analysis of transgenic thymocytes and T cells ex vivo demonstrated that inhibition of NFAT5 resulted in increased sensitivity to hyperosmotic stress as measured by cell viability, thus directly demonstrating the osmoprotective function of NFAT5 in primary cells. The observed lack of any enhanced sensitivity of transgenic T cells to other mechanisms of inducing cell death (Fig. 3, B and  D) further substantiates the conclusion that NFAT5 specifically regulates osmoprotective transcriptional responses. Transgenic T FIGURE 8. The DN NFAT5 transgene inhibits the induction of osmotic response genes. A, Con A blasts were cultured for 6 h in medium (NS), medium without amino acids (ϪAA), or hyperosmotic medium (H) containing 100 mM sucrose. Total cellular RNA was prepared and Northern analysis of the expression of the indicated genes was performed. B, Fold induction of ATA2 and AR mRNA normalized to GAPDH in nontransgenic vs transgenic T cells (quantitated from Northern analyses of independent RNA preparations, n ϭ 2). C, Con A blasts were washed and cultured in complete medium without IL-2 for 16 h, then incubated for 8 h in complete medium containing ionomycin (I, 600 nM) plus PMA (P, 10 nM) or NaCl (H, 100 mM) plus PMA (P, 10 nM). Total cellular RNA was prepared and Northern analysis of the expression of the indicated genes was performed. D, Fold induction of TNF-␣ mRNA normalized to GAPDH in nontransgenic vs transgenic T cells (quantitated from Northern analyses of independent RNA preparations, n ϭ 2). cells exhibited no impairment in growth responses or cytokine production under normal cell culture conditions (Fig. 5) , further supporting the conclusion that NFAT5 functions specifically to allow cells to optimally compensate for hyperosmotic conditions. To further investigate the osmoprotective function of NFAT5, two alternative means of inducing an osmotic stress were used. Culture under conditions of medium depletion results in a very slow increase in extracellular osmolarity, in contrast to rapid exposure of cells to hypertonic medium, which is particularly toxic to lymphoid cells (Fig. 3A and Ref. 36) . The gradual increase in extracellular osmolarity that takes place upon medium depletion (Fig.  6E ) allows for the optimal induction of adaptive compensatory mechanisms that may require hours to be fully activated, such as adaptive transcriptional responses potentially mediated by NFAT5. Consistent with this result, stable overexpression of NFAT5 in the Jurkat T cell line resulted in enhanced cell growth and viability under conditions of medium depletion, while expression of DN NFAT5 impaired cell growth and viability (Fig. 6, C and D) .
An alternative means of inducing an osmotic stress under isotonic conditions uses amino acid deprivation. Amino acid limitation induces a reduction in cell volume due to loss of intracellular amino acids, which function as compatible organic osmolytes (24, 31) . Amino acid limitation thus induces osmocompensatory mechanisms similar to those induced by exposing cells to a hypertonic environment, but it does so by loss of intracellular osmolytes under isotonic conditions rather than loss of intracellular water under hypertonic conditions (24, 31) . Interestingly, transgenic T cells exhibited impaired cell growth upon both medium depletion and amino acid deprivation (Figs. 6, A and B, and 7A ). These results indicate that NFAT5 functions to allow the cell to compensate for suboptimal growth conditions associated with osmotic stress induced by either increased extracellular osmolarity (medium depletion) or decreased intracellular osmolarity under isotonic conditions (amino acid limitation). Thus, the osmoprotective function of NFAT5 in ex vivo cultures, particularly in response to osmotic stress induced not only by extracellular hyperosmolarity but also by intracellular osmolyte loss under isotonic conditions, suggests that the observed impairment in T cell development in vivo under physiologic isosmotic conditions results from inhibition of the osmoprotective function of NFAT5.
Exposure of cells to hyperosmotic stress results in osmotic outflow of water and a concomitant reduction in cell volume, resulting in an increase in intracellular ionic strength. Cell survival requires the homeostatic maintenance of intracellular conditions within an appropriate range that is compatible with normal metabolic and biochemical function within the cell. While most cell types are capable of rapidly activating various ionic transport mechanisms to induce a regulatory volume increase in response to hyperosmotic stress (37, 38) , lymphoid cell lines as well as primary thymocytes preferentially undergo apoptosis (36) . The reduced thymic cellularity observed in the DN NFAT5 transgenic mice, as well as the increased sensitivity of both thymocytes and mature T cells to hyperosmolar stress, may thus reflect a greater dependence on NFAT5-dependent adaptive mechanisms to compensate for osmotic stress. Moreover, the extremely high density of cells within the thymus, combined with abundant apoptosis associated with thymic selection and the associated release of macromolecules that may increase extracellular osmolarity, may create a microenvironment in which NFAT5-dependent osmocompensatory mechanisms are critical. The importance of the thymic microenvironment in revealing a function for NFAT5 in vivo is highlighted by the lack of any NFAT5-specific phenotype upon culture of thymocytes or mature T cells ex vivo under normal tissue culture conditions. However, the sensitivity of thymocytes and mature T cells ex vivo to conditions associated with hyperosmotic stress provides further support for the notion that cells within the thymic microenvironment are subject to osmotic stress conditions that are optimally compensated for by NFAT5-dependent transcriptional responses.
Cell growth and physiologic osmotic stress
The present studies specifically investigate the function of NFAT5 in developing and mature T cells. However, the ubiquitous expression of NFAT5 mRNA (10, 15, 18) , and in particular the enhanced expression of NFAT5 protein in actively proliferating cells (15, 19) , suggests that the demands of cell growth may impose an osmotic stress that is relieved through transcription of NFAT5 target genes in all cell types. As described above, exposure of cells to a hypertonic environment results in a decrease in cell volume that is associated with an increase in intracellular ionic strength. NFAT5-dependent transcription of genes that increase the intracellular concentration of compatible organic osmolytes provides a means to increase cell volume, thereby restoring cell volume and intracellular ionic strength to a steady state that is optimal for normal cell function. However, with the exception of cells of the renal medulla, mammalian cells exist in an isosmotic environment.
Under isosmotic conditions, a reduction or loss of intracellular osmolytes may also lead to a functional reduction in cell volume and an increase in ionic strength that could compromise normal cellular metabolic and biochemical function. The rapid synthesis of macromolecules (e.g., proteins, nucleic acids) from low m.w. precursors (e.g., amino acids, nucleotides) that takes place concomitantly with the induction of cell growth represents one mechanism by which the concentration of organic as well as ionic osmolytes within the cell may be effectively reduced under isosmotic conditions (37, 38) . The biosynthetic demands of cell growth under isosmotic conditions may induce an osmotic stress that could be deleterious to optimal cell growth without a mechanism to compensate for the osmotic disequilibrium. Thus, the impaired thymic development observed in DN NFAT5 transgenic mice, as well as the impaired cell growth under conditions of osmotic stress, may reflect the inability of cells that are defective in NFAT5 function to completely compensate for osmotic stress associated with cell growth.
It is, of course, important to note the lack of any impairment in growth of transgenic T cells ex vivo under normal tissue culture conditions, which indicates that the level of osmotic stress inherent in cell growth under normal tissue culture conditions does not require NFAT5-dependent compensation. Rather, it may be the combination of intrinsic osmotic stress associated with cell growth in conjunction with extracellular osmotic stress within the cellular microenvironments found in vivo that gives rise to NFAT5-dependent responses that are necessary for optimal cell growth. Consistent with this, overexpression of the putative Drosophila NFAT5 homolog gives rise to both eye development and synaptogenesis phenotypes that could result from altered cell growth (21, 22) .
NFAT5 target genes
The present studies provide direct functional evidence that NFAT5 plays a role in the induction of the AR gene in response to hyperosmotic stress (Figs. 2 and 8) . Regulation of target genes that control intracellular compatible osmolyte concentrations is consistent with the observed osmoprotective function of NFAT5 demonstrated in this study. Amino acids, in addition to their function as critical cell nutrients, also function as an important class of compatible osmolytes that are depleted during cell growth as a result of the induction of protein synthesis. Thus, reduction in intracellular amino acids during cell growth may contribute to a state of osmotic stress that could, without compensation, result in impaired cell growth. Among the various amino acid transporters, function of the transport system A for neutral amino acids in particular has been shown to be osmosensitive in a variety of cell systems (32) , including rat thymocytes (39) , suggesting that genes encoding the system A transporter may be regulated by NFAT5 (24) . Analysis of the system A transporter gene ATA2 (Fig. 8, A and B) , which has been shown to be induced by hypertonicity (33, 34) , demonstrated that induction of this gene in response to extracellular hypertonicity was inhibited in cells from DN NFAT5 transgenic mice, thus indicating that NFAT5 plays a role (direct or indirect) in the osmotic regulation of the ATA2 gene. However, induction of ATA2 mRNA by amino acid deprivation was not only stronger than the induction observed with a hypertonic stimulus, but it also showed no inhibition in cells from the DN NFAT5 transgenic mice, in contrast to the AR gene. These results indicate that the ATA2 amino acid transporter gene exhibits multiple mechanisms of regulation. Given that amino acids function not only as compatible osmolytes but also as essential cell nutrients, an NFAT5-independent means of regulating the ATA2 gene is not surprising and likely results from activation of as yet poorly characterized amino acid-sensing pathways (40) .
In addition to genes that regulate intracellular compatible osmolytes, genes encoding the inflammatory cytokines TNF-␣ and lymphotoxin ␤ have also been identified as putative NFAT5 target genes (20) . In the present studies (Fig. 8, C and D) , comparison of the induction of TNF-␣ mRNA in T cell blasts from DN NFAT5 transgenic mice and transgene-negative littermate controls showed no differences, suggesting that NFAT5 is not involved in the induction of the TNF-␣ gene in primary T lymphocytes. Moreover, while stimulation with ionomycin plus PMA resulted in the induction of TNF-␣ mRNA, stimulation with PMA plus 100 mM NaCl actually resulted in a decrease in TNF-␣ mRNA levels. This result contradicts results in which an increase in the production of TNF-␣ protein, as measured by ELISA, was observed in primary T cell blasts that had been similarly treated (20) . Exposure of primary lymphocytes to hypertonic conditions resulted in significant toxicity, as reflected by a 55% reduction in the recovery of mRNA from cells incubated in 100 mM NaCl. Therefore, it is possible that an apparent increase in TNF-␣ protein production upon hypertonic stimulation (20) could result from release of intracellular protein as a result of cell death rather than an induction of TNF-␣ gene expression. However, the possibility that inhibition of the endogenous NFAT5 protein by the DN NFAT5 transgene may be insufficient to alter TNF-␣ gene expression in T cell blasts cannot be excluded. Further studies will be required to determine whether cytokine genes such as these represent physiologically relevant targets of NFAT5.
Conclusion
In summary, the results presented here reveal new insight into the biologic function of the NFAT5 transcription factor by not only demonstrating the osmoprotective function of NFAT5 in primary cells but also demonstrating that NFAT5 is necessary for optimal T cell development in vivo. Initially defined as a transcription factor that regulates the transcription of tonicity-responsive genes upon exposure to extracellular hyperosmotic stress, a condition of potentially unique physiologic relevance to cells of the renal medulla, the present data support a model in which extracellular hyperosmolarity in fact mimics osmotic stresses that occur under physiologic, isosmotic conditions, particularly within the cellular microenvironments that exist in vivo. The activation of NFAT5 in response to overt hyperosmotic stress as it occurs in the renal medulla (17) may thus represent a specialized adaptation of a physiologic osmoprotective or cell volume regulatory mechanism that is functional in essentially all cell types in vivo under isosomotic conditions (37, 38) . In this context, NFAT5 mediates adaptive cell volume increases that are necessary to reestablish conditions of intracellular ionic strength most compatible with optimal cell function by regulating the transcription of osmoregulatory genes in response to conditions of intracellular osmotic stress. Given the dynamic alterations in cell volume and ionic strength that take place during cell growth, NFAT5 may play a particularly important role in optimally compensating for normal osmotic stresses associated with actively proliferating cells in vivo. In light of the experimentally intractable problem of accurately reproducing normal cellular microenvironments ex vivo under tissue culture conditions, evaluation of this model of the biologic function of NFAT5 will require further genetic manipulation of NFAT5 function in whole animal systems.
